18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

3560 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />

Podnositelj europske MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

prijave patenta<br />

(71) (51) (97) (54)<br />

Pipe Restoration Technologies, Inc., US B23P 6/00 (2006.01)<br />

EP 2<strong>09</strong>9581 * METHODS AND SYSTEMS FOR COATING AND<br />

B22D 19/10 (2006.01)<br />

SEALING INSIDE PIPING SYSTEMS<br />

B22D 1/00 (2006.01)<br />

B05D 7/22 (2006.01)<br />

PLEXXIKON, INC., US C07D 471/04 (2006.01)<br />

EP 2086972 * COMPOUNDS MODULATING C-FMS AND/OR C-KIT<br />

A61K 31/437 (2006.01)<br />

PLEXXIKON, INC., US C07D 471/04 (2006.01)<br />

A61K 31/437 (2006.01)<br />

A61P 25/00 (2006.01)<br />

A61P 29/00 (2006.01)<br />

A61P 35/00 (2006.01)<br />

PLEXXIKON, INC., US C07D 471/04 (2006.01)<br />

A61K 31/435 (2006.01)<br />

A61P 35/00 (2006.01)<br />

Polifoam Müanyagfeldolgozó Kft., HU F16L 11/24 (2006.01)<br />

Portola Pharmaceuticals, Inc., US A61K 31/536 (2006.01)<br />

A61K 31/517 (2006.01)<br />

A61K 31/381 (2006.01)<br />

C07D 239/96 (2006.01)<br />

C07D 265/22 (2006.01)<br />

C07D 403/12 (2006.01)<br />

C07D 4<strong>09</strong>/12 (2006.01)<br />

C07D 413/12 (2006.01)<br />

C07D 413/14 (2006.01)<br />

C07D 4<strong>09</strong>/14 (2006.01)<br />

C07D 417/14 (2006.01)<br />

A61P 7/02 (2006.01)<br />

PPG B.V., NL B63B 59/04 (2006.01)<br />

C<strong>09</strong>D 5/16 (2006.01)<br />

B05D 5/00 (2006.01)<br />

B05D 5/08 (2006.01)<br />

Praecis Pharmaceuticals Incorporated,<br />

US<br />

B05D 7/16 (2006.01)<br />

C07D 233/64 (2006.01)<br />

C07D 241/04 (2006.01)<br />

C07D 241/08 (2006.01)<br />

C07D 277/28 (2006.01)<br />

C07D 285/12 (2006.01)<br />

C07C 237/20 (2006.01)<br />

C07F 9/<strong>09</strong> (2006.01)<br />

A61K 31/426 (2006.01)<br />

A61K 31/433 (2006.01)<br />

A61K 31/661 (2006.01)<br />

A61K 31/167 (2006.01)<br />

A61P 25/28 (2006.01)<br />

Pronova BioPharma Norge AS, NO C07C 69/587 (2006.01)<br />

A61K 31/202 (2006.01)<br />

A61K 31/232 (2006.01)<br />

A61P 1/16 (2006.01)<br />

A61P 29/00 (2006.01)<br />

A61P 3/04 (2006.01)<br />

A61P 3/10 (2006.01)<br />

C07C 229/30 (2006.01)<br />

C07C 323/54 (2006.01)<br />

C07C 57/13 (2006.01)<br />

C07C 69/602 (2006.01)<br />

C07C 69/732 (2006.01)<br />

C07C 69/734 (2006.01)<br />

C11C 3/00 (2006.01)<br />

A61K 49/00 (2006.01)<br />

Prosurgics Limited, GB A61B 19/00 (2006.01)<br />

Protaffin Biotechnologie AG, AT G01N 33/50 (2006.01)<br />

G01N 33/569 (2006.01)<br />

Proyecto de Biomedicina Cima, S.L., ES C12N 15/86 (2006.01)<br />

QLT Plug Delivery, Inc., US A61F 2/14 (2006.01)<br />

A61M 31/00 (2006.01)<br />

A61M 35/00 (2006.01)<br />

A61B 18/18 (2006.01)<br />

Ratiopharm GmbH, DE A61K 9/14 (2006.01)<br />

A61K 9/20 (2006.01)<br />

A61K 31/34 (2006.01)<br />

A61K 31/343 (2006.01)<br />

Reliant Exams AS, NO G<strong>09</strong>B 7/00 (2006.01)<br />

Reliant Pharmaceuticals, Inc., US A61K 31/20 (2006.01)<br />

Reliant Pharmaceuticals, Inc., US A01N 37/00 (2006.01)<br />

A61K 31/20 (2006.01)<br />

EP 2<strong>09</strong>4701 *<br />

EP 2<strong>09</strong>7414 *<br />

EP 2100067 *<br />

EP 2<strong>09</strong>4272 *<br />

EP 2086827 *<br />

EP 2<strong>09</strong>9768 *<br />

EP 2<strong>09</strong>4640 *<br />

EP 2<strong>09</strong>7035 *<br />

EP 20897<strong>09</strong> *<br />

EP 2<strong>09</strong>7533 *<br />

EP 2<strong>09</strong>7044 *<br />

EP 20865<strong>09</strong> *<br />

EP 2100285 *<br />

EP 2089014 *<br />

EP 2<strong>09</strong>9295 *<br />

ACTIVITY AND USES THEREFOR<br />

COMPOUNDS AND METHODS FOR KINASE<br />

MODULATION, AND INDICATIONS THEREFOR<br />

PYRROLO [2, 3-B]PYRIDINE DERIVATIVES AS<br />

KINASE MODULATORS<br />

DUCT ELEMENT FOR AIR HANDLING SYSTEMS<br />

NITROGEN CONTAINING SUBSTITUTED<br />

HETEROCYCLES AS PLATELET ADP RECEPTOR<br />

INHIBITORS<br />

FOULING RELEASE NEW BUILDING COATING<br />

PROCESS<br />

AGONISTS OF THE SPHINGOSINE-1-PHOSPHATE<br />

RECEPTOR<br />

ALPHA-SUBSTITUTED OMEGA-3 LIPIDS THAT ARE<br />

ACTIVATORS OR MODULATORS OF THE<br />

PEROXISOME PROLIFERATORS-ACTIVATED<br />

RECEPTOR (PPAR).<br />

FIDUCIAL MARKER PLACEMENT<br />

SYSTEM TO ASSESS THE BIOLOGICAL ACTIVITY<br />

OF CHEMOATTRACTANTS<br />

VIRAL VECTOR AND USES THEREOF<br />

DRUG DELIVERY IMPLANTS FOR INHIBITION OF<br />

OPTICAL DEFECTS<br />

ESCITALOPRAM AND SOLID PHARMACEUTICAL<br />

COMPOSITION COMPRISING THE SAME<br />

SYSTEM AND METHOD FOR IMPROVING THE<br />

QUALITY OF COMPUTER GENERATED EXAMS<br />

OMEGA-3 FATTY ACIDS AND DYSLIPIDEMIC AGENT<br />

FOR REDUCTION OF APO-B LEVELS<br />

PROPHLYAXIS AND TREATMENT OF ATRIAL<br />

FIBRILLATION WITH OMEGA-3 FATTY ACIDS<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!